Chromanol compounds for treatment of heart failure

Robert Henk Henning; Adrianus Cornelis van der Graaf; Guido Krenning; Lucas Moritz Wiggenhauser

Chromanol compounds for treatment of heart failure

Robert Henk Henning (Uitvinder), Adrianus Cornelis van der Graaf (Uitvinder), Guido Krenning (Uitvinder), Lucas Moritz Wiggenhauser (Uitvinder)

Onderzoeksoutput

38 Downloads (Pure)

Samenvatting

The invention relates to certain chromanol, quinone or hydroquinone compounds and derivatives thereof for treatment of heart failure with reduced ejection fraction (HFrEF). Specifically, the present invention relates to chromanol compounds chosen from S-(6-hydroxy-2,5,7,8-tetramethylchroman-2yl)(piperazin-1-yl)methanone and S-(6-hydroxy-2,5,7,8-tetramethylchroman-2-yl)(4-(2-hydroxyethyl)piperazin-1-yl)methanone, and pharmaceutically acceptable salts thereof.

Originele taal-2	English
Octrooinummer	WO2022058620
Prioriteitsdatum	21/09/2020
Indieningsdatum	21/09/2021
Status	Published - 24-mrt.-2022

Toegang tot document

WO202258620_A1Final publisher's version, 1,64 MB

Handle.net

Permanente koppeling

Citeer dit

@misc{f8c50465b1534642909f00e5fba35bf4,

title = "Chromanol compounds for treatment of heart failure",

abstract = "The invention relates to certain chromanol, quinone or hydroquinone compounds and derivatives thereof for treatment of heart failure with reduced ejection fraction (HFrEF). Specifically, the present invention relates to chromanol compounds chosen from S-(6-hydroxy-2,5,7,8-tetramethylchroman-2yl)(piperazin-1-yl)methanone and S-(6-hydroxy-2,5,7,8-tetramethylchroman-2-yl)(4-(2-hydroxyethyl)piperazin-1-yl)methanone, and pharmaceutically acceptable salts thereof.",

author = "Henning, {Robert Henk} and {van der Graaf}, {Adrianus Cornelis} and Guido Krenning and Wiggenhauser, {Lucas Moritz}",

year = "2022",

month = mar,

day = "24",

language = "English",

type = "Patent",

note = "WO2022058620",

}

TY - PAT

T1 - Chromanol compounds for treatment of heart failure

AU - Henning, Robert Henk

AU - van der Graaf, Adrianus Cornelis

AU - Krenning, Guido

AU - Wiggenhauser, Lucas Moritz

PY - 2022/3/24

Y1 - 2022/3/24

N2 - The invention relates to certain chromanol, quinone or hydroquinone compounds and derivatives thereof for treatment of heart failure with reduced ejection fraction (HFrEF). Specifically, the present invention relates to chromanol compounds chosen from S-(6-hydroxy-2,5,7,8-tetramethylchroman-2yl)(piperazin-1-yl)methanone and S-(6-hydroxy-2,5,7,8-tetramethylchroman-2-yl)(4-(2-hydroxyethyl)piperazin-1-yl)methanone, and pharmaceutically acceptable salts thereof.

AB - The invention relates to certain chromanol, quinone or hydroquinone compounds and derivatives thereof for treatment of heart failure with reduced ejection fraction (HFrEF). Specifically, the present invention relates to chromanol compounds chosen from S-(6-hydroxy-2,5,7,8-tetramethylchroman-2yl)(piperazin-1-yl)methanone and S-(6-hydroxy-2,5,7,8-tetramethylchroman-2-yl)(4-(2-hydroxyethyl)piperazin-1-yl)methanone, and pharmaceutically acceptable salts thereof.

M3 - Patent

M1 - WO2022058620

Y2 - 2021/09/21

ER -

Chromanol compounds for treatment of heart failure

Samenvatting

Toegang tot document

Handle.net

Vingerafdruk

Citeer dit